Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov;84(5):e13339.
doi: 10.1111/aji.13339. Epub 2020 Sep 20.

COVID-19-related disease severity in pregnancy

Jennifer L Thompson  1 , Lynsa M Nguyen  1 , Kristen N Noble  2 , David M Aronoff  3   4   5
Affiliations
Review

COVID-19-related disease severity in pregnancy

Jennifer L Thompson et al. Am J Reprod Immunol. 2020 Nov.

Abstract

The pandemic caused by COVID-19 is affecting populations and healthcare systems worldwide. As we gain experience managing COVID-19, more data become available on disease severity, course, and treatment in patients infected with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). However, data in pregnancy remain limited. This narrative review of COVID-19 during pregnancy underscores key knowledge gaps in our understanding of the impact of this viral infection on reproductive health. Current data suggest that pregnant people have similar disease course and outcomes compared to nonpregnant people, with the majority experiencing mild disease; however, pregnant people may have increased risk of hospitalization and intensive care unit (ICU) admission. Among patients who develop severe and critical disease, major maternal morbidity and mortality have been described including cardiomyopathy, mechanical ventilation, extracorporeal membrane oxygenation, and death. Many questions remain regarding maternal severity of disease in COVID-19. Further research is needed to better understand disease course in pregnancy. Additionally, the inclusion of pregnant patients in therapeutic trials will provide vital data on treatment options for patients. As we continue to treat more patients affected by SARS-CoV-2, multidisciplinary care and continued research are both needed to achieve optimal outcomes for mother and fetus.

Keywords: coronavirus; infection; pandemic; pregnancy.

PubMed Disclaimer

References

REFERENCES

    1. World Health Organization. Coronavirus disesae 2019 (COVID-19) Situation Report - 51. 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/2.... Accessed May 29, 2020
    1. Johns Hopkins University & Medicine Coronavirus Resource Center. Johns Hopkins University & Medicine. Updated June 5, 2020. Accessed May 30, 2020, 2020. https://coronavirus.jhu.edu/map.html
    1. Liu M, Wang T, Zhou Y, Zhao Y, Zhang Y, Li J. Potential role of ACE2 in coronavirus disease 2019 (COVID-19) prevention and management. J Transl Int Med. 2020;8(1):9-19.
    1. Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271-280.e8.
    1. Li M, Chen L, Zhang J, Xiong C, Li X. The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome study. PLoS One. 2020;15(4):e0230295.